UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003102
Receipt number R000003678
Scientific Title Phase I-II Study of Irinotecan and Erlotinib in Patients with Erlotinib Failure for Non-Small Cell Lung Cancer
Date of disclosure of the study information 2010/01/27
Last modified on 2019/02/04 14:37:30

No. Disposal Last modified on Item of update
1 Insert 2010/01/27 11:31:38
2 Update 2011/01/27 15:54:44 Interventions/Control_1
3 Update 2012/01/04 17:31:48 Organization
Division name
Address
Organization
Division name
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Address
Institute
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Address1
Email1
4 Update 2014/10/04 20:29:30 Email
Address
Address
Email
Email
5 Update 2015/07/27 09:05:26 Recruitment status
6 Update 2018/06/14 12:43:47 Name of primary person or sponsor
Organization
Email1
7 Update 2019/02/04 14:37:30 Recruitment status